LY3473329
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY3473329, covering 2024-10-28 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events [Phase 2]